- Home
- CNTX vs CCLD Comparison
CNTX vs CCLD Comparison
Compare CNTX & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- CCLD
- Stock Information
- Founded
- CNTX 2015
- CCLD 1999
- Country
- CNTX United States
- CCLD United States
- Employees
- CNTX N/A
- CCLD N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- CNTX Health Care
- CCLD Technology
- Exchange
- CNTX Nasdaq
- CCLD Nasdaq
- Market Cap
- CNTX 78.0M
- CCLD 105.8M
- IPO Year
- CNTX 2021
- CCLD 2014
- Fundamental
- Price
- CNTX $0.63
- CCLD $2.34
- Analyst Decision
- CNTX Strong Buy
- CCLD Buy
- Analyst Count
- CNTX 5
- CCLD 2
- Target Price
- CNTX $5.50
- CCLD $3.00
- AVG Volume (30 Days)
- CNTX 324.1K
- CCLD 546.8K
- Earning Date
- CNTX 08-06-2025
- CCLD 08-12-2025
- Dividend Yield
- CNTX N/A
- CCLD N/A
- EPS Growth
- CNTX N/A
- CCLD N/A
- EPS
- CNTX N/A
- CCLD N/A
- Revenue
- CNTX N/A
- CCLD $112,507,000.00
- Revenue This Year
- CNTX N/A
- CCLD $2.74
- Revenue Next Year
- CNTX N/A
- CCLD $7.52
- P/E Ratio
- CNTX N/A
- CCLD N/A
- Revenue Growth
- CNTX N/A
- CCLD N/A
- 52 Week Low
- CNTX $0.49
- CCLD $1.14
- 52 Week High
- CNTX $2.75
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- CNTX 50.76
- CCLD 53.40
- Support Level
- CNTX $0.62
- CCLD $2.26
- Resistance Level
- CNTX $0.70
- CCLD $2.47
- Average True Range (ATR)
- CNTX 0.05
- CCLD 0.16
- MACD
- CNTX 0.01
- CCLD -0.01
- Stochastic Oscillator
- CNTX 56.44
- CCLD 51.97
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.